Admelog and Pregabalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Admelog (insulin lispro) and Pregabalin (pregabalin). Common drug interactions include respiratory syncytial virus infection among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Admelog and Pregabalin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Admelog?

Admelog has active ingredients of insulin lispro. eHealthMe is studying from 1,268 Admelog users. Check the latest studies of Admelog.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.



On Jul, 06, 2026

13 people who take Admelog and Pregabalin together, and have interactions are studied.

Admelog and Pregabalin drug interactions.

What are the common drug interactions of Admelog and Pregabalin, by gender? *:

female:

  1. Respiratory syncytial virus infection (viral disease of respiratory system)
  2. Arrhythmia (irregular heartbeat)
  3. Cardiac arrest
  4. Chest pain
  5. Depression
  6. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  7. Hypertension (high blood pressure)
  8. Obesity (having too much body fat)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

male:

  1. Fatigue (feeling of tiredness)
  2. Hospitalisation
  3. Nausea (feeling of having an urge to vomit)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anorectal varices (dilation of collateral submucousal vessels due to backflow in the veins of the rectum)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Bradycardia (abnormally slow heart action)
  8. Cardiomegaly (increased size of heart than normal)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Cholecystitis (infection of gallbladder)

What are the common drug interactions of Admelog and Pregabalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anorectal varices (dilation of collateral submucousal vessels due to backflow in the veins of the rectum)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Bradycardia (abnormally slow heart action)
  4. Cardiomegaly (increased size of heart than normal)
  5. Cholecystitis (infection of gallbladder)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Chronic kidney disease
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Diarrhoea
  10. Drug intolerance (drug sensitivity)

60+:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Haematochezia (passage of stools containing blood)
  4. Iron deficiency anaemia
  5. Death

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  2. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 15.38%
  3. Pain: 2 people, 15.38%
  4. Diabetes: 2 people, 15.38%
  5. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 15.38%
  6. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 2 people, 15.38%
  7. Peripheral Swelling: 2 people, 15.38%
  8. Pain In Extremity: 1 person, 7.69%
  9. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 7.69%
  10. Asthma: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Admelog and Pregabalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Admelog and Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Admelog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Admelog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro and pregabalin (the active ingredients of Admelog and Pregabalin, respectively), and Admelog and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: